Meiwu Technology Announces $14 Million Direct Offering
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 6 days ago
0mins
Should l Buy WNW?
Source: Newsfilter
- Financing Scale: Meiwu Technology has entered into an agreement to sell 6,999,996 ordinary shares at $2.00 each, expecting gross proceeds of approximately $14 million, which will enhance the company's liquidity to support future growth.
- Warrant Issuance: The company will also issue the same number of warrants to investors with an exercise price of $2.00 per share and a one-year term, further incentivizing investor participation in the company's long-term growth.
- Transaction Timeline: The transaction is expected to close on March 18, 2026, subject to customary closing conditions, ensuring timely access to funds to support the company's operations and expansion plans.
- Compliance and Transparency: This offering is made under an effective F-3 registration statement, ensuring compliance with SEC regulations, which enhances investor confidence and improves market transparency.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy WNW?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on WNW
About WNW
Meiwu Technology Co Ltd, formerly Wunong Net Technology Co Ltd, is a holding company mainly conducts online and mobile commerce business through its online retail store on its website. The Company is committed to providing customers with non-genetically modified food products through its portfolio of suppliers. Through its subsidiaries, the Company operates three segments: Clean Food Platform segment, Restaurant segment, and others segment. Its food products are categorized into green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications and pollution-free products. The Company mainly conducts its businesses within the China market.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Share Purchase Agreement: Meiwu Technology has signed an agreement with investors to sell 6,999,996 ordinary shares at $2 per share, with gross proceeds expected to be around $14 million, indicating the company's proactive approach to financing.
- Warrant Issuance: The company also issued warrants to purchase approximately 7 million shares at the same price of $2 each, valid for one year from issuance, providing investors with additional investment opportunities while potentially securing future cash inflows for the company.
- Significant Stock Drop: Meiwu Technology's shares plummeted approximately 69% during intraday trading, falling from a previous close of $2.15 to $0.67, reflecting market concerns regarding the company's financing strategy and its impact on future performance.
- Expected Transaction Closure: The transaction is anticipated to close on or about March 18, 2026, and despite the current poor stock performance, successful completion of the deal could provide the company with much-needed capital to drive future growth.
See More
- Funding Size: Meiwu Technology has entered into an agreement to sell 6,999,996 ordinary shares at a price of $2.00 per share, expecting total gross proceeds of approximately $14 million, which will provide crucial financial support for the company's operations and growth.
- Warrant Issuance: The company will also issue the same number of warrants to investors at an exercise price of $2.00 per share, with a one-year term, providing additional investment opportunities and enhancing market confidence.
- Transaction Timeline: The transaction is expected to close on March 18, 2026, subject to customary closing conditions, and the timely influx of funds will aid the company's responsiveness in the market.
- Compliance and Transparency: This offering is made under an effective F-3 registration statement, ensuring compliance and transparency, which further enhances investor trust and supports future fundraising activities.
See More
- Financing Scale: Meiwu Technology has entered into an agreement to sell 6,999,996 ordinary shares at $2.00 each, expecting gross proceeds of approximately $14 million, which will enhance the company's liquidity to support future growth.
- Warrant Issuance: The company will also issue the same number of warrants to investors with an exercise price of $2.00 per share and a one-year term, further incentivizing investor participation in the company's long-term growth.
- Transaction Timeline: The transaction is expected to close on March 18, 2026, subject to customary closing conditions, ensuring timely access to funds to support the company's operations and expansion plans.
- Compliance and Transparency: This offering is made under an effective F-3 registration statement, ensuring compliance with SEC regulations, which enhances investor confidence and improves market transparency.
See More
- AI Initiative Launch: Meiwu Technology has announced the introduction of an artificial intelligence initiative aimed at enhancing research collaboration and operational efficiency in its functional skincare business by integrating AI data analysis tools to better organize and analyze growing research data.
- Data Management Improvement: This initiative will support internal research coordination, product formulation analysis, and collaboration with external research partners, with expectations to improve the organization and review of historical formulation data and ingredient studies, thereby enhancing product development efficiency.
- Technological Application Outlook: CEO Zhichao Yang noted the increasing use of AI analytical tools in research-intensive industries, anticipating that this will strengthen collaboration between internal teams and external research partners while optimizing the evaluation process of formulation data to drive product innovation.
- Long-term Development Goals: Meiwu Technology aims to leverage this strategy to enhance its skincare product portfolio and supply chain ecosystem, ultimately achieving a more efficient product development process to respond to changing market demands and growth.
See More
- AI Insights Initiative: Meiwu Technology has announced the launch of a strategic artificial intelligence insights initiative aimed at enhancing research collaboration and operational efficiency within its functional skincare business, which is expected to significantly improve internal research coordination and collaboration with external partners.
- Data Management Optimization: The initiative will assist the company in organizing and evaluating a growing body of research data, including formulation records, ingredient studies, and scientific publications related to skincare technologies, thereby improving the efficiency of reviewing technical materials and identifying potential product development directions.
- Support for External Collaboration: By integrating AI-supported analytical tools, the company aims to enhance collaboration with external research institutions and product development partners, facilitating standardized data sharing of historical formulation data and technical materials, which will improve product development efficiency.
- Market Expansion Potential: As the company continues to expand its functional skincare product portfolio and supply chain ecosystem, improvements in internal research coordination and data management are expected to provide more efficient support for future product development processes, thereby enhancing market competitiveness.
See More
- AI Initiative Launch: Meiwu Technology has announced a strategic artificial intelligence (AI) initiative aimed at enhancing R&D collaboration and operational efficiency in its functional skincare business, utilizing AI-assisted data analysis tools to support internal research coordination and product formulation analysis.
- Data Management Optimization: This initiative is expected to help the company organize and evaluate an increasing volume of research data, including formulation records and ingredient studies, thereby improving the efficiency of technical document reviews and accelerating the product development process.
- Enhanced External Collaboration: Meiwu aims to improve collaboration with external research institutions and product development partners through AI analysis tools, facilitating standardized data sharing and identifying potential interactions between ingredients, thus enhancing overall R&D capabilities.
- Market Expansion Potential: This move not only supports the company's ongoing expansion in the skincare market but also has the potential to strengthen its position in a competitive landscape by improving R&D efficiency and product development speed.
See More








